SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Ripple Erik Spencer

(Last) (First) (Middle)
C/O INGEVITY CORPORATION
4920 O'HEAR AVE, SUITE 400

(Street)
NORTH CHARLESTON SC 29405

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
04/26/2022
3. Issuer Name and Ticker or Trading Symbol
Ingevity Corp [ NGVT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Growth & Innov Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 11,473 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) (1) 02/28/2028 Common Stock 834 74.91 D
Employee Stock Option (Right to Buy) (2) 02/28/2029 Common Stock 828 115.22 D
Employee Stock Option (Right to Buy) (3) 02/28/2030 Common Stock 1,575 45.04 D
Employee Stock Option (Right to Buy) (4) 02/26/2031 Common Stock 2,536 69.48 D
Employee Stock Option (Right to Buy) (5) 02/28/2032 Common Stock 3,407 68.23 D
Explanation of Responses:
1. These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan, as amended (the "OIP"), and became exercisable on February 28, 2021.
2. These options are granted pursuant to the OIP, and became exercisable ratably on February 28, 2020, 2021, and 2022.
3. These options are granted pursuant to the OIP. 787 options became exercisable on February 28, 2022, and the remaining 788 options will become exercisable on February 28, 2023.
4. These options are granted pursuant to the OIP. 846 options became exercisable on February 26, 2022. The remaining 1,690 options will become exercisable ratably on February 26, 2023 and 2024.
5. These options are granted pursuant to the OIP, and will become exercisable ratably on February 28, 2023, 2024, and 2025.
Remarks:
Exhibits: Exhibit 24 - Power of Attorney
/s/ Erik Ripple By: Mavis Huger as Attorney-in-Fact 05/06/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.